Información del artículo
El Texto completo está disponible en PDF
References
[1.]
M.S. Lim, L. Leval, L. Quintanilla-Martínez.
Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms.
J Hematopathol, 2 (2009), pp. 65-73
[2.]
A.G. Jegalian, F. Facchetti, E.S. Jaffe.
Plasmacytoid dendritic cells: physiologic roles and pathologic states.
Adv Anat Pathol, 16 (2009), pp. 392-404
[3.]
L. Cerroni, T. Wiesner.
Cutaneous lymphomas: from morphology to chip technology.
Actas Dermosifiliogr, 100 (2009), pp. 3-17
[4.]
V. López, N. Martí, A. Ferrández, J.M. Martin, E. Jordá.
An atypical presentation of a blastic plasmacytoid dendritic cell tumors.
J Cutan Pathol, 37 (2010), pp. e50-e52
[5.]
C. Cota, E. Vale, I. Viana, L. Requena, G. Ferrara, L. Anemona, et al.
Cutaneous manifestations of blastic plasmacytoid dendritic cell neoplasm-morphologic and phenotypic variability in a series of 33 patients.
Am J Surg Pathol, 34 (2010), pp. 75-87
[6.]
T. Marafioti, J.C. Paterson, E. Ballabio, K.K. Reichard, S. Tedoldi, K. Hollowood, et al.
Novel markers of normal and neoplastic human plasmacytoid dendritic cell.
Blood, 111 (2008), pp. 3778-3792
[7.]
K.M. Kaune, M. Baumgart, H.P. Bertsch, C. Mitteldorf, H.K. Müller-Hermelink, D. Haase, et al.
Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.
Am J Dermatopathol, 31 (2009), pp. 695-701
[8.]
S. Dalle, M. Beylot-Barry, M. Bagot, D. Lipsker, L. Machet, P. Joly.
Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice?.
Br J Dermatol, 162 (2010), pp. 74-99
[9.]
A.L. Kedward, C. McGalie, L. Venkatraman, J. Hamilton, M. El-Agnaf, K. McKenna.
Plasmacytoid dendritic cell neoplasm treated successfully with rituximab.
J Eur Acad Dermatol Venereol, 24 (2010), pp. 742-743
[10.]
D.L. Jaye, C.M. Geigerman, M. Herling, K. Eastburn, E.K. Waller, D. Jones.
Expression of the plasmacytoid dendritic cell marker BDCA-2 supports a spectrum of maturation among CD4+ CD56+ hematodermic neoplasms.
Mod Pathol, 19 (2006), pp. 1555-1562
Copyright © 2011. Academia Española de Dermatología y Venereología and Elsevier España, S.L.
